Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
CRISPR QC’s CRISPR Analytics Platform™ is a quantitative kinetic analysis platform for gene-editing R&D and manufacturing workflows. Its core goal is to help teams move beyond simply asking “did the edit work?” to understanding “why did it succeed or fail?” Built on the CRISPR-Chip™ graphene biosensor, it provides in vitro real-time analysis for observing RNP formation, DNA target binding, and cleavage activity in CRISPR-Cas systems.
The platform is not focused on general-purpose laboratory information management, but rather on measuring CRISPR biochemical mechanisms. The RNP formation module can be used to pre-screen gRNA efficiency, confirm assembly of Cas-gRNA complexes, optimize multiplexed gRNAs and their ratios, and identify batch-to-batch differences in gRNAs or enzymes. DNA target binding measures the binding kinetics between RNPs and target DNA amplicons in real time, helping teams compare candidate designs or Cas proteins. The Cleavage module emphasizes highly sensitive, real-time detection of cleavage efficiency and activity differences. Typical users include gene-editing research teams, therapeutic development teams, CDMOs, and biomanufacturing teams.
The official website does not disclose plans, pricing, free trials, payment methods, or whether the offering is a pure cloud SaaS product, an instrument platform, a testing service, or a hybrid delivery model. Judging from the workflow of “contact the team — design a pilot — run measurements — deliver a report,” it appears to lean more toward a specialized scientific service and platform-based testing solution. There is also no clear information on third-party integrations, APIs, permission management, data export, or developer support.
Its main strength is that it targets upstream mechanistic analysis for troubleshooting CRISPR failures. Before running expensive sequencing or cell-based experiments, teams can use quantitative readouts to compare gRNAs, Cas proteins, dosages, buffers, batches, and suppliers, reducing blind optimization. The website also emphasizes support from a scientific team to help design measurement plans and deliver recommendations. The limitation is that key enterprise software procurement details are incomplete, especially around pricing, compliance, security, deployment, and system integration, making it difficult to assess IT implementation costs.
Access from mainland China cannot be determined from the available site content, and payment methods are not disclosed. If cross-border research services, sample shipment, or instrument procurement are involved, teams will need to further confirm compliance, logistics, and contract arrangements. Comparable options include Benchling, Synthego, IDT CRISPR tools, GenScript CRISPR services, and domestic gene-editing service providers in China. Overall, it is best suited for professional teams with clear CRISPR optimization and quality-control needs that are willing to co-design experimental plans with the vendor.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on crisprqc.com official site.
crisprqc.com is an United States Health provider. TG4G tracks its product information, an overall rating of 8.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach crisprqc.com directly.